CYTOCHALASIN B

CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with CYTOCHALASIN B?

CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B

MeSH term MeSH ID Detail
Uremia D014511 33 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Starvation D013217 47 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Asthma D001249 52 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Melanoma D008545 69 associated lipids
Leukemia D007938 74 associated lipids
Alzheimer Disease D000544 76 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Insulin Resistance D007333 99 associated lipids
Glioma D005910 112 associated lipids
Hypertension D006973 115 associated lipids
Inflammation D007249 119 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hemolysis D006461 131 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Body Weight D001835 333 associated lipids
Per page 10 20 50 100 | Total 79

PubChem Associated disorders and diseases

What pathways are associated with CYTOCHALASIN B

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with CYTOCHALASIN B?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with CYTOCHALASIN B?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with CYTOCHALASIN B?

Xenograft Model

Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with CYTOCHALASIN B

Download all related citations
Per page 10 20 50 100 | Total 4982
Authors Title Published Journal PubMed Link
Hsu PY and Yang YW Gene delivery via the hybrid vector of recombinant adeno-associated virus and polyethylenimine. 2014 Eur J Pharm Sci pmid:24184196
Fayeulle A et al. Energy-dependent uptake of benzo[a]pyrene and its cytoskeleton-dependent intracellular transport by the telluric fungus Fusarium solani. 2014 Environ Sci Pollut Res Int pmid:24271730
Trendowski M et al. The real deal: using cytochalasin B in sonodynamic therapy to preferentially damage leukemia cells. 2014 Anticancer Res. pmid:24778021
Olivero OA et al. Selective protection of zidovudine-induced DNA-damage by the antioxidants WR-1065 and tempol. 2014 Environ. Mol. Mutagen. pmid:24833597
Chun JT et al. Early events of fertilization in sea urchin eggs are sensitive to actin-binding organic molecules. 2014 Biochem. Biophys. Res. Commun. pmid:24960199
Shirazi A et al. Developmental competence of ovine oocyte following vitrification: effect of oocyte developmental stage, cumulus cells, cytoskeleton stabiliser, FBS concentration, and equilibration time. 2014 Zygote pmid:22892096
Tong ZG et al. Cytochalasin B inhibits the proliferation of human glioma U251 cells through cell cycle arrest and apoptosis. 2014 Genet. Mol. Res. pmid:25526201
Bułdak RJ et al. Changes in subcellular localization of visfatin in human colorectal HCT-116 carcinoma cell line after cytochalasin B treatment. 2014 Eur J Histochem pmid:25308845
Balajee AS et al. Multicolour FISH analysis of ionising radiation induced micronucleus formation in human lymphocytes. 2014 Mutagenesis pmid:25217771
Liaw CC et al. New briarane diterpenoids from Taiwanese soft coral Briareum violacea. 2014 Mar Drugs pmid:25153765
Soueidan OM et al. New fluorinated fructose analogs as selective probes of the hexose transporter protein GLUT5. 2015 Org. Biomol. Chem. pmid:25975431
Hosseini SM et al. Chemically assisted somatic cell nuclear transfer without micromanipulator in the goat: effects of demecolcine, cytochalasin-B, and MG-132 on the efficiency of a manual method of oocyte enucleation using a pulled Pasteur pipette. 2015 Anim. Reprod. Sci. pmid:25956201
Simic MR et al. Synthesis of novel tetrahydrobenzazepine derivatives and their cytoprotective effect on human lymphocytes. 2015 Arch. Pharm. (Weinheim) pmid:25664628
Lim JH et al. Olfactory receptor screening assay using nanovesicle-immobilized carbon nanotube transistor. 2015 Methods Mol. Biol. pmid:25563185
Trendowski M et al. Enlargement and multinucleation of u937 leukemia and MCF7 breast carcinoma cells by antineoplastic agents to enhance sensitivity to low frequency ultrasound and to DNA-directed anticancer agents. 2015 Anticancer Res. pmid:25550536
Lamour G et al. Substrate-induced PC12 cell differentiation without filopodial, lamellipodial activity or NGF stimulationa. 2015 Macromol Biosci pmid:25350917
Wright KM and MacKenzie KM Probing protein targeting to plasmodesmata using fluorescence recovery after photo-bleaching. 2015 Methods Mol. Biol. pmid:25287209
White RG Probing plasmodesmata function with biochemical inhibitors. 2015 Methods Mol. Biol. pmid:25287206
Huang CY et al. Glaucumolides A and B, Biscembranoids with New Structural Type from a Cultured Soft Coral Sarcophyton glaucum. 2015 Sci Rep pmid:26531161
Trendowski M et al. Effects of cytochalasin congeners, microtubule-directed agents, and doxorubicin alone or in combination against human ovarian carcinoma cell lines in vitro. 2015 BMC Cancer pmid:26357852